Effective January 2018, the HPV Investigator Studies Program (MISP) Committee will accept proposals within our current areas of interest (AOI) up to April 23, 2018. This is a competitive process that will be conducted on May 24, 2018 by the HPV MISP. Decisions will be made on the basis of scientific merit and strategic fit within the AOI. Please review the critical activities and abide by the timelines as outlined below.
The following areas are of interest to Investigator Studies Program Committee:
Research that
- Studies the use of social media or other tools to increase HPV vaccination series completion
- Elucidates the pathogenesis of HPV-related oropharyngeal cancer (OPC) and the relevance of persistent oral infection as a surrogate endpoint for OPC
- Studies the effectiveness of vaccinating women and men ages 27-45 years of age to prevent HPV persistent infection and disease where labeled
- Pilots methods to demonstrate reducing prevalence of HPV infection and eventual elimination of high grade CIN and cervical cancer through HPV vaccination
Please complete a full protocol and detailed budget via Visiontracker, the Company's on-line study management system (in US) or your MSD country representative (outside US). The proposals will be collectively reviewed and selected by the HPV MISP Committee.
Critical Activities and Timelines:
| Deadline Dates/Activity | Review Cycle |
|---|---|
| Full Protocol Submission with Detailed Budget | April 23, 2018 |
| Final Comments to Investigator | June 18, 2018 |
For more information, please visit: http://engagezone.msd.com/HPV.php